Go Ad-Free
logoThe People's Perspective on Medicine

Avandia and Actos Compared to Insulin

A different study of diabetes drugs showed that Avandia and its competitor Actos are neither better nor worse than injected insulin in preventing death from cardiovascular complications of type 2 diabetes. The study was partially funded by the National Institutes of Health and lasted five years. During that time, 11.8 % of those on Actos or Avandia died, compared to 12.1 % of those on insulin. There is no statistical difference between these treatments. The investigators were disappointed that there was no clear benefit from the newer and more expensive diabetes drugs.

[American Diabetes Association scientific meeting, June, 2009]

Rate this article
0- 0 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies..
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.